Howard E Bond

Title: Howard E Bond - Innovator in Immunoglobulin Conjugation

Introduction

Howard E Bond is a notable inventor based in Lake Forest, IL (US). He has made significant contributions to the field of immunology through his innovative patent work. His expertise lies in the development of processes that enhance the functionality of immunoglobulins.

Latest Patents

Howard E Bond holds a patent for the "Site-specific conjugation of immunoglobulins and detectable labels." This patent describes a process for producing a derivatized immunoglobulin, which involves introducing sulfhydryl groups in the Fc region of an immunoglobulin without altering the Fab portion. The resulting derivatized immunoglobulin is utilized to create conjugates with various detectable moieties, ensuring a controlled distance between the Fc region and the detectable moiety. These conjugates are particularly beneficial for immunoassays, offering improved longevity, specificity, and sensitivity. He has 1 patent to his name.

Career Highlights

Howard E Bond is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions that advance medical diagnostics and therapeutic applications.

Collaborations

Throughout his career, Howard has collaborated with talented individuals such as Christopher Bieniarz and Mazhar Husain. These collaborations have contributed to the development of groundbreaking technologies in the field of immunology.

Conclusion

Howard E Bond's contributions to immunoglobulin conjugation represent a significant advancement in medical diagnostics. His innovative approach continues to influence the field and improve the effectiveness of immunoassays.